title: Managing oral anticoagulant therapy.
authors.affiliation: Department of Medicine, Boston University Medical Center, MA 02118, USA. jack.ansell@bmc.org
authors.forename: J
authors.initials: J
authors.lastname: Ansell
authors.forename: J
authors.initials: J
authors.lastname: Hirsh
authors.forename: J
authors.initials: J
authors.lastname: Dalen
authors.forename: H
authors.initials: H
authors.lastname: Bussey
authors.forename: D
authors.initials: D
authors.lastname: Anderson
authors.forename: L
authors.initials: L
authors.lastname: Poller
authors.forename: A
authors.initials: A
authors.lastname: Jacobson
authors.forename: D
authors.initials: D
authors.lastname: Deykin
authors.forename: D
authors.initials: D
authors.lastname: Matchar
mesh_terms: D000284:Administration, Oral; D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome; D001780:Blood Coagulation Tests; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D019934:International Normalized Ratio; D008962:Models, Theoretical; D011247:Pregnancy; D012307:Risk Factors
chemical_list: D000925:Anticoagulants